Cargando…
Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest
BACKGROUND: There are several medical treatment options for endometrioma. Progestin, especially dienogest, is an effective drug for preventing recurrence of endometrioma after surgery. Additionally, oral contraceptive (OC) use after conservative surgery has been reported to reduce significantly the...
Autores principales: | Choi, Seung-Hye, Kim, Sung Eun, Lim, Hyun Hye, Lee, Dong-Yun, Choi, DooSeok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259244/ https://www.ncbi.nlm.nih.gov/pubmed/35790209 http://dx.doi.org/10.3346/jkms.2022.37.e207 |
Ejemplares similares
-
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial
por: Muraoka, Ayako, et al.
Publicado: (2021) -
Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017) -
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023) -
Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery
por: Tang, Mingjun, et al.
Publicado: (2023) -
GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients
por: Park, Hyun Jung, et al.
Publicado: (2010)